0:000:00
<p><span data-sheets-value= "{"1":2,"2":"<p>This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.</p><p><b>Coverage of stories discussed this week on ascopost.com:</b></p><p><a href=\"https://ascopost.com/news/october-2020/fda-approves-venetoclax-combination-regimen-for-certain-adult-patients-with-aml/\">FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML</a></p><p><a href=\"https://ascopost.com/news/october-2020/fda-extends-the-approval-of-pembrolizumab-for-patients-with-classical-hodgkin-lymphoma/\">FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma</a><br></p><p>To listen to more podcasts from ASCO, visit <a href=\"https://www.asco.org/about-asco/asco-digital/podcasts\">asco.org/podcasts</a>. <br></p>"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we'll focus on two recent approvals from the U.S. Food ...